Endocrine system disorder

Related records

Broader conditions (3)

• Disease
• Disease by body system or component
• Human disease

Narrower conditions (1,681)

• 17-alpha-hydroxylase/17,20-lyase deficiency, combined complete
• 17-alpha-hydroxylase/17,20-lyase deficiency, combined partial
• 17,20-lyase deficiency, isolated
• 45,X/46,XY mixed gonadal dysgenesis
• 46 XX gonadal dysgenesis
• 46 XY differences of sex development
• 46,XX disorder of sex development
• 46,XX disorder of sex development-anorectal anomalies syndrome
• 46,XX disorder of sex development-skeletal anomalies syndrome
• 46,XX ovarian dysgenesis-short stature syndrome
• 46,XX ovotesticular disorder of sex development
• 46,XX sex reversal 1
• 46,XX sex reversal 2
• 46,XX sex reversal 3
• 46,XX sex reversal 4
• 46,XX testicular disorder of sex development
• 46,XX true hermaphroditism, SRY-positive
• 46,XY complete gonadal dysgenesis
• 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
• 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency

Trials (348)

• "Iron Overload and Endocrinological Diseases"
• "PTHrP(1-36) IV Dose Escalation Study"
• 12 Weeks of Resistance Band Exercise Impacts on Adiposity, Hormones, and Blood Pressure in Postmenopausal Women
• 3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women
• 7 Day Continuous Parathyroid Hormone IV Infusion
• A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity
• A BHI to Increase Hope Level and Stress Level of Parents With a CMC
• A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg
• A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
• A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
• A Pharmacokinetic Study of MK-3102 in Participants With Impaired Hepatic Function (MK-3102-031)
• A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males
• A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
• A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
• A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
• A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
• A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator
• A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
• A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic Primary Hyperparathyroidism

Approved drugs (4)

• Hydrocortisone
• Methylprednisolone
• Prednisone
• Somatropin

Drugs in development (1)

• Omega-3-acid ethyl esters Phase 3

Other linked drugs (1)

• Metformin